0001181431-14-036855.txt : 20141119
0001181431-14-036855.hdr.sgml : 20141119
20141119164957
ACCESSION NUMBER: 0001181431-14-036855
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141117
FILED AS OF DATE: 20141119
DATE AS OF CHANGE: 20141119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levy Richard S
CENTRAL INDEX KEY: 0001454983
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 141236064
MAIL ADDRESS:
STREET 1: EXPERIMENTAL STATION
STREET 2: ROUTE 141 AND HENRY CLAY RD
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
rrd419044.xml
X0306
4
2014-11-17
0
0000879169
INCYTE CORP
INCY
0001454983
Levy Richard S
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Chief Drug Dev&Medical Of
Common Stock
2014-11-17
4
M
0
12000
14.72
A
30205
D
Common Stock
2014-11-17
4
S
0
12000
69.97
D
18205
D
Non-Qualified Stock Option (right to buy)
14.72
2014-11-17
4
M
0
12000
0
D
2018-01-24
Common Stock
12000
32317
D
Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents weighted average sale price. Actual sales prices ranged from $69.12 - $70.69.
Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares.
/s/ Richard S. Levy
2014-11-19